Dan Nasko

Develop and implement bioinformatics workflows for secondary analysis of Next-Generation Sequencing (NGS) data, including PacBio HiFi, SBB, Illumina, and Nanopore platforms, supporting oncology and microbiome research for internal and external clients. Perform data analysis and create visualizations in Python and R Markdown to evaluate variant calling performance across NGS platforms.

Collaborate with R&D and marketing teams to design and execute experiments, contributing to the creation of marketing collateral.

Develop and deploy automated, data science-driven infrastructure for microbiome research, integrating shotgun metagenomics, 16S, metabolomics, metatranscriptomics, and open-source databases. Conduct biological discovery of novel bacterial and phage probiotic candidates from human and animal gut samples to advance disease treatment and promote healthy development.

Leverage machine learning techniques to analyze microbial signatures from subsurface samples, enabling the identification of reservoir sources and their characteristics. By integrating metagenomic data with advanced algorithms, this approach uncovers patterns in microbial communities that correlate with specific reservoir conditions, such as temperature, pressure, and geochemical profiles. These insights aid in tracing reservoir connectivity, assessing production potential, and optimizing resource management strategies in energy exploration and production. Acquired by Novozymes in March 2021.